Dompe farmaceutici s.p.a. - REP0121, A multicenter, randomized, doubleblind, placebo-controlled phase 2study to assess the efficacy and safety of oralreparixin in cancer related fatigue in patients with locally advanced ormetastatic breast cancer und

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences